Stockreport

Got $2,000? These Biotech Stocks Are Worth Considering for Long-Term Growth [Globe and Mail, The (Toronto, Canada)]

Regeneron Pharmaceuticals, Inc.  (REGN) 
Last regeneron pharmaceuticals, inc. earnings: 2/6 06:30 am Check Earnings Report
US:NASDAQ Investor Relations: investor.regeneron.com
PDF Regeneron has an exciting lineup of candidates, including some in the industry's hottest area. Some investors might choose to stay out of the famously volatile biotec [Read more]